Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220863 · ClinicalTrials.gov registry record
Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai
A clinical trial of Breast Cancer Awareness, sponsored by Feminai.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT07220863: Recruiting study of Breast Cancer Awareness, sponsored by Feminai.
NCT07220863 is a study of Breast Cancer Awareness that is actively recruiting participants, run by Feminai. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07220863, a study of Breast Cancer Awareness, is actively recruiting participants, sponsored by Feminai.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective observational study evaluating the safety and accuracy of Feminai 1.0, an at-home adhesive patch that measures skin temperature and electrical impedance to map each breast. Up to 300 women (ages 25-75) undergoing screening will have one study visit; Feminai results will be compared with mammography and, when available, biopsy to assess sensitivity and negative predictive value. Feminai is investigational, intended to support clinical decision-making, and does not replace standard diagnostic tests.
Conditions Studied
Study Locations (1)
Texas
- Solis Mammography Frisco at Stonebriar - Frisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-10-05 |
| Est. Completion | 2026-09-05 |
What NCT07220863 shows while recruiting
NCT07220863 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Breast Cancer Awareness appearing as the primary indexed condition, and to 0 interventions.
NCT07220863 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07220863 about?
NCT07220863 is a clinical study titled "Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai". Prospective observational study evaluating the safety and accuracy of Feminai 1.0, an at-home adhesive patch that measures skin temperature and electrical impedance to map each breast. Up to 300 women (ages 25-75) undergoing screening will have one study visit; Feminai results will be compared with ...
What is the current status of trial NCT07220863?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-10-05. Estimated completion is 2026-09-05.
What conditions does trial NCT07220863 study?
This clinical trial studies the following conditions: Breast Cancer Awareness.
Who is sponsoring clinical trial NCT07220863?
This trial is sponsored by Feminai, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07220863 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Awareness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI